Concepedia

Richard E. Royal

RE

Statistics

Publications

75

Citations

18.9K

H-Index

49

Active since

1995

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

National Cancer Institute

National Institutes of Health

Society of Surgical Oncology

Center for Cancer Research

Richard E. Royal is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

1995–2023

75

Publications

75

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

Richard A. Morgan, Mark E. Dudley, John R. Wunderlich et al. · Science · 2006 · 2.6K citations · Full text

Medicine, Immunology, Oncology +14

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang et al. · Journal of Clinical Oncology · 2005 · 1.6K citations · Full text

Medicine, Immunology, Oncology +17

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Laura A. Johnson, Richard A. Morgan, Mark E. Dudley et al. · Blood · 2009 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +17

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Mark E. Dudley, James Chih‐Hsin Yang, Richard M. Sherry et al. · Journal of Clinical Oncology · 2008 · 1.3K citations · Full text

Medicine, Immunology, Oncology +17

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Richard E. Royal, Catherine Lévy, Keli Turner et al. · Journal of Immunotherapy · 2010 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 75